Trusted Press Release Distribution   Plans | Login    

Briefing Search


Author Details
Precision Business Insights
Rajesh k
Precision Business Insights, Kemp House, 152 – 160 City Road,

Bookmark and Share
Attention Deficit Hyperactivity Treatment Disorder Market | Size ,Share , Forecast 2019-2025
The Attention Deficit Hyperactivity Treatment Market is anticipated to reach about US$ XX Bn by 2025,, 6/14/2019 - The Attention Deficit Hyperactivity Treatment Market is anticipated to reach about US$ -- Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to increasing healthcare expenditure & rising prevalence of ADHD.

Precision Business Insights (PBI) in its report titled “Attention Deficit Hypersensitive Treatment Disorder Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. However, there are some factors which can hinder growth of the market including medical complications of existing drug therapies, high domination of generic pharmaceutical market and strict government protocols.

Attention deficit hyperactivity treatment market segmented on the basis of medicine type, age group and distribution channel.

Adult Age Group Expected to Dominate the Market

On the basis of age group, the market has been segmented into pediatric and adolescent, and adults. The adults age group segment accounted for highest revenue share of --% in 2015, and is expected to retain its dominance throughout the forecast period.

Retail Pharmacies Will Dominate the Revenue Share.

North America, Accounts for Major Revenue Share for Market

Precision Business Insights (PBI) attention deficit hyperactivity treatment market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America is expected to dominate the global ADHD therapeutics market owing to the presence of clinical ongoing trials, quick FDA approval of therapeutics, existence of innovative brain monitoring technologies coupled with insurance policies, and government support for technological advancements.

For request sample:

U.S.FDA Approvals Play Vital Role in Attention Deficit Hypersensitivity Treatment Market

Some of the key players are actively promoting their products by adopting various market strategy which sheers their footprint in the global market. In June 2017, Shire Plc received U.S. FDA approval for a long-acting attention-deficit drug Adderall XR aimed at adolescents and adults

Detailed Segmentation

By Medicine Type

o Stimulants

• Amphetamines

• Methylphenidate

• Dextroamphetamine

• Dexmethylphenidate

o Non-Stimulants

• Atomoxetine

• Bupropion

• Guanfacine

By Age Group Type

o Paediatric

o Adolescent

o Adults

By Distribution Channel Type

o Hospital pharmacies

o Specialty clinics

o Retail pharmacies

o Online pharmacies


o North America

? U.S.

? Canada

o Europe

? Germany

? UK

? France

? Russia

? Spain

? Italy

? Rest of Europe

o Asia-Pacific

? China

? Japan

? India


? Rest of Asia Pacific

o Latin America

? Brazil

? Mexico

? Argentina

? Chile

? Rest of Latin America

o Middle East and Africa

? South Africa

? Saudi Arabia

? Rest of MEA

For more information:

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.